Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects

OBJECTIVE: Develop a cerebrospinal fluid biomarker signature for mild Alzheimer’s disease (AD) in Alzheimer’s Disease Neuroimaging Initiative (ADNI) subjects. METHODS: Amyloid-β 1 to 42 peptide (Aβ(1-42)), total tau (t-tau), and tau phosphorylated at the threonine 181 were measured in (1) cerebrospi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shaw, Leslie M., Vanderstichele, Hugo, Knapik-Czajka, Malgorzata, Clark, Christopher M., Aisen, Paul S., Petersen, Ronald C., Blennow, Kaj, Soares, Holly, Simon, Adam, Lewczuk, Piotr, Dean, Robert, Siemers, Eric, Potter, William, Lee, Virginia M.-Y., Trojanowski, John Q.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2696350/
https://ncbi.nlm.nih.gov/pubmed/19296504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21610
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados